Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Terragen Holdings Ltd ( (AU:TGH) ) has provided an update.
Terragen Holdings Limited has completed the issue of 191,927,526 fully paid ordinary shares at $0.022 each under an institutional placement, executed without a prospectus under the Corporations Act disclosure exemptions. The company confirmed it is up to date with its financial reporting and continuous disclosure obligations and stated there is no excluded information requiring disclosure, effectively clearing the way for on-market trading of the new shares and reinforcing regulatory compliance for existing and new investors.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
More about Terragen Holdings Ltd
Terragen Holdings Limited is an Australian agritech company that develops biological products for agricultural applications, using naturally occurring live microbial strains to improve plant and animal productivity. The company currently markets Terragen Probiotic for Ruminants and its plant biostimulant Great Land Plus in Australia and New Zealand, and is pursuing a broader commercialisation strategy through growing sales, product trials and distribution discussions.
Average Trading Volume: 224,539
Technical Sentiment Signal: Sell
Current Market Cap: A$13.26M
Find detailed analytics on TGH stock on TipRanks’ Stock Analysis page.